enVVeno Medical Corp (NVNO) stock
NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$5.77+0.00 (0.00%)
Close on Nov 18, 2026Market cap $4.01MP/E –Yield –
enVVeno Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
enVVeno Medical's ebitda for the twelve months ending Mar 31, 2026 was -$19.88M. For fiscal 2025 it was -$20.76M. The highest annual figure on record is -$5.96M in fiscal 2017.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$20.76M | – |
| FY2024 | Dec 31, 2024 | -$23.64M | – |
| FY2023 | Dec 31, 2023 | -$25.02M | – |
| FY2022 | Dec 31, 2022 | -$24.72M | – |
| FY2021 | Dec 31, 2021 | -$16.74M | – |
| FY2020 | Dec 31, 2020 | -$9.04M | – |
| FY2019 | Dec 31, 2019 | -$7.55M | – |
| FY2018 | Dec 31, 2018 | -$7.72M | – |
| FY2017 | Dec 31, 2017 | -$5.96M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$4.03M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.98M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.02M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.91M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.66M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.13M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.40M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.76M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.74M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.41M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.10M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.93M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.28M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.95M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.66M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.78M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.13M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.90M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.52M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.49M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.26M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.80M | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.93M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.56M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.77M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.45M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.08M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.42M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.90M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.78M | – |
See a number that looks wrong?